Alomide

Alomide is a brand name of lodoxamide ophthalmic, approved by the FDA in the following formulation(s):

ALOMIDE (lodoxamide tromethamine - solution/drops; ophthalmic)

• 
  Manufacturer: ALCON
  
  Approval date: September 23, 1993
  
  Strength(s): EQ 0.1% BASE ^[RLD]

Has a generic version of Alomide been approved?

No. There is currently no therapeutically equivalent version of Alomide available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Alomide. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Use of lodoxamide to treat ophthalmic allergic conditions
  Patent 5,457,126
  Issued: October 10, 1995
  Inventor(s): Aoki; K. Roger & DeSantis; Louis M.
  Assignee(s): Alcon Laboratories, Inc.
  Disclosed are methods of using certain defined phenylene dioxamic acids in treating allergic ocular responses, such as, hayfever, conjunctivitis, atopic and keratoconjunctivitis, vernal conjunctivitis, giant capillary conjunctivitis and other diseases where mast cell degranulation are important in the etiology, by topical administration of said active to the affected eye; also disclosed are pharmaceutical compositions comprising said actives.
  
  Patent expiration dates:
  
  
  • October 10, 2012
    
    ✓ 
    Patent use: TREATMENT OF OCULAR ALLERGIC RESPONSE IN HUMAN EYES
  
  

See also...

• Alomide Consumer Information (Wolters Kluwer)
• Alomide Consumer Information (Cerner Multum)
• Alomide Advanced Consumer Information (Micromedex)
• Alomide AHFS DI Monographs (ASHP)
• Lodoxamide Consumer Information (Wolters Kluwer)
• Lodoxamide ophthalmic Consumer Information (Cerner Multum)
• Lodoxamide Ophthalmic Advanced Consumer Information (Micromedex)
• Lodoxamide Tromethamine AHFS DI Monographs (ASHP)